TIME

TOPIC

SPEAKER

9.00AM – 9.10AM

Opening

9.00AM – 9.05AM

Welcome address

Dr. Marcus Klein

9.05AM – 9.10AM

Opening remark

Dr. Yoshikatsu Eto

Identification of Fabry patients

Chairperson: Dr. Toya Ohashi

                          Dr. Mark Thomas

9.10AM – 9.30AM

Fabry disease overview - genetics and disease manifestation

Dr. Yoshikatsu Eto

9.30AM – 9.50AM

Fabry screening based on renal manifestations

Dr. Helen Healy

9.50AM – 10.10AM

Fabry screening based on cardiac manifestations

Dr. Geu-Rue Hong

10.10AM – 10:25AM

Q&A

All

10.25AM – 10:45AM

Break

Management of Fabry disease I

Chairperson: Dr. Norio Sakai

                             Dr. Han-Wook Yoo

10.45AM – 11.15AM

Factors to be considered when selecting the treatment

Dr. Frank Weidemann

11.15AM – 11.45AM

Available biomarkers and proper use of the biomarkers for better patient monitoring in Fabry disease

Dr. Ozlem Goker-Alpan

11.45AM – 12.00PM

Q&A

All

12.00PM – 12.50PM

Lunch

Japanese case presentations

Chairperson: Dr. Yoshikatsu Eto

12.50PM – 1.05PM

Japanese case presentation 1

Dr. Yasuhiro Izumiya

1.05PM – 1.20PM

Japanese case presentation 2

Dr. Kotaro Nochioka

1.20PM – 1.35PM

Japanese case presentation 3

Dr. Koji Higuchi

1.35PM – 1.50PM

Japanese case presentation 4

Dr. Kaoru Eto

1.50PM – 2.00PM

Q&A

All

Management of Fabry disease II

Chairperson: Dr. Ozlem Goker-Alpan

2.00PM – 2.40PM

Global recommendations on treatment of adult patients with Fabry disease

Dr. Frank Weidemann

2.40PM – 3.00PM

Family screening in Fabry disease: its importance and a success story

Dr. Norio Sakai

3.00PM – 3.20PM

Q&A

All

3.20PM – 3.30PM

Closing Remark

Dr. Yoshikatsu Eto